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Background: Patients with addictions and concurrent disorders constitute the most underserved population in the
system of care. There are numerous reasons why this population has so much difficulty accessing services,
including behavioural issues, criminal engagement, and non-compliance with outpatient services. To improve
services to this population which is marked by multiple morbidities, high mortality and insufficient access to health
care, the government of British Columbia, Canada developed a program for people with both substance use
disorder and one or more mental disorders who have not benefited from previous therapies.
Method: In July 2008, the Burnaby Treatment Centre for Mental Health and Addiction (BCMHA), a specialized and
integrated tertiary care facility, was opened. The current article provides a description of the treatment program and
a clinical profile of the population.
Results: The target population is being served, at intake clients present with high rates of psychopathology,
childhood and adult trauma, and substance use.
Conclusion: While preliminary, these results indicate, that the novel approach of the Burnaby Centre may
constitute a new path towards providing effective recovery for this population.
Keywords: Concurrent disorders, Integrated treatment, Marginalized populationsBackground
Individuals with concurrent mental and substance use
disorders tend to present with multiple physical health
problems and substantial social and behavioural prob-
lems [1]. Individuals with concurrent disorders (CD) are
overrepresented in forensic settings, regularly inhabit
substandard housing [2,3] and constitute a significant
percentage of the homeless population [4,5]. Individuals
suffering from CD typically have difficulty engaging with
traditional health care services and tend to rely heavily
upon emergency care as their access point to the health* Correspondence: ilinden@cheos.ubc.ca
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reproduction in any medium, provided the orcare system [6]. The CD population exhibits extremely
poor health outcomes and has a life expectancy that is
considerably lower than the general population [7,8].
These and other concerns were recently emphasized by
a group of leading American psychiatrists in a recent
‘call for action’ [9].
In the Canadian province of British Columbia (BC),
the highest numbers of patients with CD and those with
the most severe problems are found within inner-city
neighbourhoods. In Vancouver, the area known as the
Downtown Eastside (DTES) has a particularly high con-
centration of CD clients and has been the focus of con-
siderable efforts to develop special treatment programs,
including low threshold or harm reduction approaches
[10]. Although there are existing treatment programs forLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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many health care providers in the DTES have expressed
concern that these services are inaccessible to CD clients
[11,12]. In longitudinal studies, having CD was associated
with lower motivational readiness to change, lack of treat-
ment engagement and attendance, and poor medication
compliance [13,14]. Many of these individuals have ‘be-
havioural issues’, such as high impulsivity, aggression, and
involvement in criminal activity [15]. These dysfunctional
behaviours may be an expression of street entrenched life,
mental disorders, substance intoxication/dependence, or a
combination of all of these dimensions. Unfortunately,
these types of behaviours will often disqualify CD clients
from health services, and bring individuals into frequent
contact with the criminal justice system [16]. Resources
could be more effectively allocated if these concurrent
conditions were treated consistently and if the available
therapies were better tailored to the realities of this
vulnerable population [17].
Development of a treatment model for individuals with
CD in British Columbia
Despite an influx of resources into this vulnerable neigh-
bourhood over the past 20 years, the health concerns
facing DTES residents and clients with CD throughout
the province of BC have not been resolved. Therefore, in
2008, an overall consensus for significant change drove
the creation of a new approach to managing the health
issues of CD clients. The development of a specialized
program for clients with CD was mandated by the pro-
vincial government of BC. In April 2008, funding for
the development of a specialized, 100 bed provincial
treatment facility was announced, and in July of 2008,
the Burnaby Treatment Centre for Mental Health and
Addiction (BCMHA) was opened. The founding principles
of BCMHA were developed by a panel of experts with
ranging specialties from substance abuse treatment,
psychological therapy and rehabilitation as well as repre-
sentatives from acute care, community care, and forensic
services. The model of care was designed to incorporate
principles of strength-based care and the concepts of
assertive treatment, motivation-based treatment, time-
unlimited treatment, comprehensive programming, treat-
ment approaches tailored to the receptiveness of clients
(e.g. starting at low intensity), harm reduction leading to
abstinence, stepped care, and cultural competence and sen-
sitivity [18]. The BCMHA emphasizes two key strategies: 1)
the management of relapse and crisis as the basis of achiev-
ing recovery for patients, and 2) long-term rehabilitation-
focused care, reflecting a core belief that while recovery is a
long process-it is the only alternative to reduce the serious
mortality in this population.
The BCMHA was deemed to be a tertiary care pro-
gram and given the mandate to provide comprehensivecare to individuals with CD who present with severe
mental health, physical health, substance use, and be-
havioural issues. Comprehensive care was defined as
including all stages of treatment for each dimension of
care, including withdrawal management, psychiatric care
(excluding emergency care), psychosocial care, and medical
care (excluding emergency/acute care).
The treatment program is designed for clients to stay
up to 9 months at the inpatient facility/treatment program;
thus reflecting the extensive change required during
recovery from concurrent disorders. Although clients
are encouraged to stay 9 months, there is considerable
flexibility, as some clients will require shorter involvement
while others will benefit from long-term care, therefore the
center does not have strict and arbitrary time limits. The
treatment team consists of care providers including psychi-
atrists, psychologists, physicians, nurses, counsellors, health
care workers, social workers, in addition to occupational
therapists, art and music therapists, and providers of
alternative medicine. Treatment goals are determined
in team meetings with the client. Treatment is based
on best evidence as provided by international treatment
guidelines and reviews of treatment efficacy. Treatment
includes individual and group interventions targeting
specific issues such as relapse prevention, contingency
management, anger management, and motivational
interviewing. Interventions are offered at different levels
of complexities, allowing an individual to progress from
simpler, low intensity approaches to more demanding
and intensive interventions. Table 1 describes the different
treatment components available to clients at BCMHA.
Concurrently, clients receive medication treatment for
mental health and medical issues. Clients are encouraged
to progress from tightly supervised medical treatment to a
weekly handout of medication.
The Provincial Health Services Authority (PHSA), who
established access protocols under which the five regional
health authorities in British Columbia could refer CD cli-
ents to the BCMHA, organizes the referral process for the
BCMHA. According to the access protocol, the patients
must have failed other programs on a regional level and
must have significant issues in each of the four identified
domains: mental health, substance use, physical health
and behavioural. Furthermore, clients eligible for ad-
mission must have been unable to adequately engage
with, receive services from, or benefit from traditional
mental health and addiction programs.
The centre’s mandate was to meet the needs of the
vulnerable population in BC, and to help a population
whose complexity of daily living made it difficult for them
to benefit from existing services. As clients at the BCMHA
are both difficult to engage in treatment and present with
extremely challenging combinations of health problems,
the present study’s objective is to describe the needs of
Table 1 BCMHA recovery and clinical pathway model
Treatment Goals Treatment elements
Recovery 1
(20–40 days)
• Complete the withdrawal management process • Medication treatment by psychiatrists and GPs.
One-to-one sessions with psychiatrists and counsellors.
• Stabilize all medical and psychiatric disorders
• Stabilize sleep patterns • Complimentary therapies e.g.
• Reduce behavioural and emotional instability • acupuncture and yoga.
• Group programs include: Motivational Enhancement,
Anger Management, Early Recovery - Substances (Matrix),
Early Recovery - Mental Health, Emotional Boot Camp
(introductory), Life Skills, Talking Circle.
• Introduce a range of healthy habits
• Prepare residents to participate in structured educational,




• Provide clients with a basic understanding of the nature of
addiction and mental health problems
• Continued medical follow-up, therapy sessions
and complimentary therapies.
• Teach clients techniques for self- managing emotions and behaviours • Group programs include: Emotional Bootcamp, Anger
Management, Seeking Safety, Cognitive Behavioural
Therapy (for psychosis and affective disorders), Emotional
Boot Camp, Mindfulness, Relapse Prevention (Matrix),
Living Free, Life Skills, Talking Circle, Stages of Change,
• Allow clients to explore a range of creative and recreational activities
• Introduce clients to techniques for managing substance
use and mental health problems
• Work on developing a personal strengths inventory • Hep C treatment group.
• Recreational activities and Art therapy
Recovery 3
(40–60 days)
• Identify a secure housing situation • Continuation of Recovery 2 programs as well as
Life Management, Stepping Up and Stepping Out.
• Establish a financial and vocational plan
• Connecting the client with community organizations and resources,
including connecting clients with the Ministry of Housing and
Income Assistance (former MIEA) and other providers
• Community activity and involvement is supported.
• Self-medication plans initiated.
• Developing and implementing a relapse prevention plan, including
connections with treatment providers in the community as appropriate
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outline the level of mental illness in this population
and to inform planning and tailoring of treatment ser-
vices for these difficult to treat clients. A description of
the characteristics of the client population and their
initial responses to the intervention are presented.
Methods
This program evaluation consisted of a baseline assess-
ment, and a follow up assessment at 6 months. Baseline
data were collected from June 2009 to January 2010, and
follow up assessment began in December 2009 and were
completed in March 2010. All potential participants in
the study were adult residents of the BCMHA who had
been admitted in accordance with a standardized access
process that was regulated by the BC Provincial Health
Services Authority [19]. One hundred and twenty-eight
clients who were consecutively admitted to the BCMHA
were contacted to take part in an assessment, and
assessed for eligibility by the intake team. We completed
the baseline assessment for the pre-test within 6 weeks
of intake. Clients were asked to respond in their baseline
assessment regarding their status at intake. A total of
112 clients consented to participate in the study and 92
participants completed the minimal baseline assessment.
Baseline information included information on mentaldisorders, substance use patterns, and health status. Due
to funding restrictions that prevented tracking of pa-
tients who were discharged or had dropped out of the
study, follow-up interviews were completed only of indi-
viduals who were still at the treatment centre. This study
was reviewed and approved by the University of British
Columbia Research Ethics Board.
We collected demographic information, which included
age, gender, ethnicity, education, recent employment, and
housing situation.
Mini-International Neuropsychiatric Interview (MINI)
Plus [20] is a structured clinical interview to assess current
and lifetime substance use and mental disorders according
to the criteria of the Diagnostic and Statistical Manual, 4th
edition (DSM-IV).
Childhood Trauma Questionnaire, short form (CTQ-SF)
[21] is a retrospective self-report inventory that assessed
different types of childhood maltreatment on five subscales:
Physical Abuse, Emotional Abuse, Sexual Abuse, Physical
Neglect, and Emotional Neglect. The questionnaire consists
of 28 items answered on a 5-point Likert scale, including
three items to assess minimization/denial. We adopted the
severity classification proposed by the developers.
Trauma History Questionnaire (THQ) [22] is a 24-item
self-report measure that examines experiences with
potentially traumatic events, including crime-related
Table 2 Client’s demographic characteristics
Variables N = 92 (%)










≥ high school exam 27 (29.3%)





Fixed Address 29 (31.5%)
SRO* 12 (13.1%)
Shelters/Surfing 22 (23.9%)
Living on the street/homeless 29 (31.5%)
*SRO: Single Room Occupancy (generally substandard housing).
Table 3 BSI dimensions scores and composite GSI score, and










Mean (SD) Mean (SD) Mean (SD)
Somatization 1.43 (1.02) 1.69 (1.04) 1.14 (0.84) .006
Obsess.-Compuls. 2.11 (1.05) 2.29 (1.11) 1.67 (1.09) .0004
Interp. Sensitivity 1.92 (1.20) 2.07 (1.22) 1.50 (1.14) .0014
Depression 2.08 (1.16) 2.21 (1.17) 1.40 (1.06) <.0001
Anxiety 1.90 (1.13) 2.11 (1.20) 1.40 (1.08) <.0001
Hostility 1.48 (1.05) 1.59 (1.09) 1.19 (1.02) .0258
Phobic Anxiety 1.44 (1.15) 1.66 (1.24) 0.97 (0.99) <.0001
Paranoid Ideation 1.77 (1.06) 1.96 (1.10) 1.52 (0.94) .0024
Psychoticism 1.77 (0.96) 1.83 (0.99) 1.29 (0.99) .0004
GSI 1.78 (0.91) 1.94 (0.95) 1.31 (0.83) <.0001
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accidents, natural or man-made disasters, war, injury,
life-threatening illnesses, or deaths of others), and sexual
and physical assault. For each item, the clients were asked
to indicate the frequency and at what age they had experi-
enced the event.
The Brief Symptom Inventory (BSI) [23] is a 53 item
self-report questionnaire that measures nine dimensions
of psychological distress over the past 7 days using a five-
point Likert scale. The nine dimensions are: Somatization,
Obsession-Compulsion, Interpersonal Sensitivity, Depres-
sion, Anxiety, Hostility, Phobic Anxiety, Paranoid Ideation
and Psychoticism. In addition to the average score for each
individual dimension, we calculated the Global Severity
Index (the average score of all items combined) as a
measure of overall current distress.
The Maudsley Addiction Profile (MAP) [24] is a self-
report measurement that assesses current substance
use related problem behaviours. Participants were asked to
indicate the frequency, amount, and route of adminis-
tration of alcohol, cocaine (powder or crack cocaine),
cannabis, opioids (heroin, nonprescribed methadone,
or nonprescribed opioids), amphetamines (amphetamines
or crystal methamphetamines), and nonprescribed benzodi-
azepines they used in the past 30 days.
Descriptive analyses were used to describe the sample,
including numbers and percentages for dichotomized
sociodemographic and clinical variables, and means and
standard deviations (SD) for continuous variables. Com-
parison between baseline and follow-up MAP and BSI
measures were assessed as indicators of the client’s pro-
gress in treatment. Within this matched analysis, paired
t-test and chi-square test were employed to examine the
mean differences and the differences in proportions. All
reported p-values are two-tailed and significance was set
at p ≤ 05. Analysis was performed using SAS version 9.1
(SAS Institute, Inc, Cary, North Carolina).
Results
Ninety-two participants completed the baseline assessment.
The mean age at baseline was 40.2 years, and 21.7% identi-
fied as Aboriginal. Complete client demographic character-
istics can be found in Table 2. The average length of stay at
BCHMA for all clients discharged in 2010 was 4.8 months.
On the BSI, clients at intake scored highest in dimensions
of obsession-compulsion (2.11) and depression (2.08).
However, symptoms for all dimensions on the BSI were
high. Full scores for the BSI can be found in Table 3.
Extremely high rates of trauma were found in this
population using the CTQ and the THQ. More than half
of the sample had experiences at least one form of
trauma in their childhood; the most frequently reported
experience was emotional abuse. On the THQ, general
disasters and crime related events were most frequentlyreported. The full results for trauma histories are presented
in Table 4.
Results from the MAP revealed high rates of substance
use, with crack or powder cocaine use the most common
substance used at 65.2%. The complete list of substances
used is found in Table 5.
The MINI revealed that for lifetime mental disorders,
major depressive episodes was the most frequently reported
Table 4 Results of the Childhood Trauma Questionnaire
(CTQ, n = 75) and the Trauma History Questionnaire
(THQ, n = 84)
CTQ subscales n (%)
Emotional Abuse
no to low 24 (32.0%)
moderate to severe 51 (68.0%)
Physical Abuse
no to low 26 (34.7%)
moderate to severe 49 (65.3%)
Sexual Abuse
no to low 33 (44.0%)
moderate to severe 42 (56.0%)
Emotional Neglect
no to low 32 (42.7%)
moderate to severe 43 (57.3%)
Physical Neglect
no to low 32 (42.7%)
moderate to severe 43 (57.3%)
Trauma History Questionnaire n (%)
Physical Assault (yes) 55 (65.5%)
Sexual Assault (yes) 37 (44.0%)
Crime–related events (yes) 65 (77.4%)
General Disaster (yes) 69 (82.1%)
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dependence (78.4%) was more frequently reported than
alcohol dependence (65.9%). The complete list of lifetime
prevalence rates of mental and substance use disorders
can be found in Table 6.
A total of 47 clients (51%) completed the follow-up
assessment after six months. There was a significant
reduction in psychopathology symptoms from intake
to 6 months across all BSI dimensions. The means and SDs
of the baseline and the follow-up BSI scores can be found
in Table 3, along with the p-values for the comparisons.Table 5 Prevalence of substance use at baseline for all clients, a
individuals available for follow up (n = 47)





Crack or powder cocaine 60 (65.2%)
Illicit methadone 5 (5.4%)
Illicit benzodiazepines 14 (15.2%)
Amphetamine 12 (13.0%)
Injection Drug Use 32 (34.8%)
Sharing syringes 2 (2.2%)Specifically, participants improved in dimensions of
somatization (t(46) = 4.489, p = .006), obsessive-compulsive
(t(46) = 3.900, p = .0004), interpersonal sensitivity (t(46) =
3.428, p = .0014), depression (t(46) = 5.239, p < .0001),
anxiety (t(46) = 4.507, p = <.0001), hostility (t(46) = 2.304,
p = .0258), phobic anxiety (t(46) = 4.778, p < .0001), paranoid
ideation (t(46) = 3.209, p = .0024), psychoticism (t(46) =
3.739, p = .0004), and the GSI (t(46) = 5.204, p < .0001).
Even after using a Bonferroni correction to account for
multiple testing (resulting in an alpha of .005), the differ-
ences from baseline to follow-up remained significant on
all dimensions except somatisation and hostility.
Results from the MAP indicated reduction of substance
use to overall minimal use. The numbers and percentages
of substance use at baseline versus follow-up are presented
in Table 5. Specifically, the rates decreased significantly
for alcohol (χ2(1) = 7.42, p = .006), heroin (χ2(1) = 4.97,
p = .026), and cocaine (χ2(1) = 19.3, p < .0001). Using a
Bonferroni correction resulted in an alpha of .0083, indi-
cating that the changes remained significant for alcohol
and cocaine use. The differences from baseline to follow-
up were not significant for illicit methadone (χ2(1) = 1.90,
p = .168), benzodiazepines (χ2(1) = 1.79, p = .181), and
amphetamines (χ2(1) = 1.79, p = .181).
Discussion
The present study focused on describing a residential
treatment program designed to address the needs of in-
dividuals with chronic and severe concurrent conditions.
The data from the baseline assessments clearly presents
that this population was suffering from severe concurrent
disorders at the time of intake to the clinic. Compared to
normative data provided by the authors of the BSI, the
psychopathology distress not only exceeded the psy-
chopathology of the general population, but also the
psychopathology found among psychiatric inpatients [23].
The high levels of mental illness, concurrent disorders,
and multiple traumatic experiences present in this popula-
tion clearly demonstrate the importance of comprehensive
and integrated care to achieve sustainable recovery.nd comparisons of baseline and follow-up substance use for
aseline of those assessed
at FU n = 47 (%)
Follow-up
n = 47 (%)
p
16 (34.0%) 5 (10.6%) .006
15 (31.9%) 6 (12.8%) .026
30 (63.8%) 9 (19.1%) <.0001
4 (8.5%) 1 (2.1%) .168
7 (14.9%) 3 (6.4%) .181
7 (14.9%) 3 (6.4%) .181
- -
- -
Table 6 Patient’s lifetime prevalence rates of DSM-IV
based mental and substance use disorder diagnoses
Diagnoses N = 88 (%)
Major depressive episode 57 (64.8%)
Manic(Hypo-manic) episode 36 (40.9%)
Dysthymia 2 (2.3%)
Psychotic episode not induced by substances 49 (55.7%)
Panic disorder 30 (34.1%)
Agoraphobia 43 (48.9%)
Posttraumatic stress disorder 38 (43.2%)
Antisocial-personality disorder 32 (36.4%)
Alcohol dependence 58 (65.9%)
Drug dependence 69 (78.4%)
History of suicide attempt(s) 52 (59.1%)
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and addiction separately based on different philosophies
of care. While many mental health services are increasing
their treatment to include individuals with “mild to moder-
ate” forms of substance dependence, and addiction services
are increasing their treatment to include individuals with
mild to moderate mental disorders, it is the individual with
complex, severe, and concurrent conditions, that is still
caught in the gap left between two incomplete and often
incompatible treatment models [1,17]. However, increas-
ingly are integrated treatment approaches of concurrent
substance use and mental disorders accepted to be the
most promising and best practice strategy [25].
Reflecting on the presented health issues in this sample,
it is important to note the severity of problems present, and
yet the limited access to care. This sample displayed major
mental illness, trauma, and substance use, and although
each of these issues requires medical attention, the clients’
access to care prior to involvement with BCMHA was
extremely limited. The high level of traumatic experiences
from early childhood to adulthood presents a chronic
condition that needs more attention both as a contributing
factor to mental disorder and substance use order and as a
potential roadblock to accessing services. Integrated treat-
ment approaches that address both trauma/PTSD and sub-
stance use have shown some initial promising results but
need to be further refined and evaluated [26]. Recovery and
reintegration into society is only possible with a compre-
hensive and integrated long-term concept, including hous-
ing and social support. Stimulant use in this population is
high as they are low in cost and broadly available, resulting
in chronic substance use patterns that include a range
of psychotropic substances and routine polysubstance
use. Therefore, treatment must address polysubstance
use, rather than dependence to one substance in particular.
As a result of the referral process, it is expected that
these clients represent the most complex populations inmental health and addiction care in BC. BC’s population
is concentrated with about 60% in the metropolitan area
of Vancouver and the lower mainland. It seems that access
is more limited from some areas, such as very rural areas
compared to cities and the metropolitan area of Vancouver.
This was not specifically assessed, but may constitute an
area of interest for further follow up.
The manner in which the BCMHA program under-
stands and responds to relapse is central to the program.
Relapse is a regular occurrence in substance use and CD
clients, and was often the reason that BCMHA clients
had been discharged from other programs or from housing
facilities. Discharge often resulted in these clients living on
the street despite their severe mental, addictive, and
physical illnesses. From our experience with BCMHA
we have learned that a comprehensive program can be used
to achieve significant gains, as shown by the improvement
in psychopathological symptoms and decreased substance
use even before clients achieved abstinence or before men-
tal health problems are fully resolved. These data suggest
that it is possible to provide effective integrated care for
patients who have not achieved full abstinence and who re-
quire longer-term care before being able to stay abstinent,
as demonstrated by an average length of stay of 4.8 months,
as compared to many 12-week programs.
Limitations
Our study has some methodological limitations that
warrant discussion. Two important domains were not
addressed sufficiently given the major health concerns
in this population. First, the level of cognitive functioning
and all related conditions, due to mild traumatic brain
injury, and fetal alcohol spectrum disorder, etc. Second,
the presence of possible Axis II personality and develop-
mental disorders. The assessment of both domains is
time consuming and needs highly trained interviewers.
These areas need to be the focus of future studies. The
high rates of chronic substance use behaviours and disor-
ders raise concerns about the interference of substance use
symptoms (e.g., intoxication or withdrawal) with proper
psychiatric assessment. Although the reported mental
disorder symptoms and diagnoses are based on stan-
dardized assessments, over- or underestimation cannot
be excluded, given the level of our patient’s impairment
and the complexity of concurrent conditions. Further-
more, participant’s information on both baseline and
follow-up substance use behaviours was derived via
self-reports without any biochemical validation, and thus
may be affected by reporting bias. Similarly, self-reported
information on trauma histories in childhood and adult-
hood was not confirmed by external sources and may be
over- or underestimated in our study.
A major limitation of the follow-up results is the fact
that they were based on the minority of patients who
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does this attrition result in low statistical power, but it is
also very likely that these individuals are not representa-
tive of all patients accessing the BCMHA. As such, our
follow-up results need to be regarded as preliminary and
suggestive, and have to be confirmed with more systematic
data collection that assesses mental health and substance
use outcomes over a longer follow-up time period using an
intention-to-treat approach. Finally, lack of a control condi-
tion, treatment attendance and compliance measures for
patients, and treatment fidelity or manual adherence
measures for staff limits conclusions regarding the actual
impact of the specific psychiatric intervention. However, we
hope that this initial data will provide incentive for a more
comprehensive analysis of the situation of individuals with
complex concurrent disorders.
Conclusions
As indicated earlier, the eligibility criteria for the BCMHA
includes demonstrated failure in other treatment programs;
BCMHA serves as a “last resort” tertiary care facility. There
are no comparable, specialized programs in Canada focus-
sing on these high need clients [27], which makes the
BCMHA particularly interesting and challenging from both
a system and a research perspective. With an interdisciplin-
ary approach, it is possible to retain and support clients
with the highest complexity of mental and substance disor-
ders into treatment and achieve significant improvements.
The current study does not seek to identify the roadblocks
to accessing care, however, this is an important feature that
needs to be further investigated into, as appropriate health
care delivery is only achieved if and once appropriate
services are accessed.
Many of the patients who participated in this study
were never appropriately assessed before admission to
BCMHA. Although a high prevalence of traumatic expe-
riences or impairments in the cognitive functioning were
known about these clients, no neuropsychological tests,
brain imaging, or standardized psychometric tests in
those fields were documented in the files or mentioned
by them. Without standardized assessment or systematic
outcome control it is hard to develop an appropriate
care plan and provide the necessary supports. The need
for better multi-dimensional assessment is a core pre-
requisite of any professional care for this population in
the future. The consequences of all these poor health
outcomes are devastating for this high need and high
risk population, their families, their peers, and especially
their children. The lack of appropriate capacity and
quality of care needs to be addressed as a health crisis.
For individuals with the highest morbidity, access and
quality of care need to be improved. The approach
offered by the BCMHA may constitute a decisive step
towards this direction.Competing interests
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